Compounds > ci 988
Page last updated: 2024-09-02

ci 988 and loxiglumide

ci 988 has been researched along with loxiglumide in 2 studies

Compound Research Comparison

Studies
(ci 988)		Trials
(ci 988)		Recent Studies (post-2010)
(ci 988)		Studies
(loxiglumide)		Trials
(loxiglumide)		Recent Studies (post-2010) (loxiglumide)
147814257549

Protein Interaction Comparison

ProteinTaxonomyci 988 (IC50)loxiglumide (IC50)
Cholecystokinin receptor type AHomo sapiens (human)0.195

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackmore, M; Doherty, E; Hirst, BH; Manning, JE1
Rakovska, A1

Other Studies

2 other study(ies) available for ci 988 and loxiglumide

ArticleYear
Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
    International journal of cancer, 1994, May-01, Volume: 57, Issue:3

    Topics: Benzamides; Benzodiazepinones; Cell Division; Devazepide; Gastrins; Humans; Indoles; Kidney Neoplasms; Meglumine; Phenylurea Compounds; Proglumide; Receptors, Cholecystokinin; Tumor Cells, Cultured; Wilms Tumor

1994
Cholecystokinin-GABA interactions in rat striatum.
    Neuropeptides, 1995, Volume: 29, Issue:5

    Topics: Animals; Calcium; Cholecystokinin; Corpus Striatum; Electric Stimulation; gamma-Aminobutyric Acid; Hormone Antagonists; Indoles; Male; Meglumine; Proglumide; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Tetrodotoxin; Tritium

1995